title: High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience.
authors: Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. jameel_muzaffar@yahoo.com
authors: Jameel
authors: J
authors: Muzaffar
authors: Saad
authors: S
authors: Usmani
authors: Al-Ola
authors: AO
authors: Abdallah
authors: Elias
authors: E
authors: Anaissie
authors: Michele
authors: M
authors: Cottler-Fox
authors: Alejandro
authors: A
authors: Restrepo
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis / Q000628:therapy*; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D019562:Viral Load